VKP-17498-24783
4 vaccinations
1 coded response
27 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 117 / NY
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WL8-41404-90942
Child or adolescent in my care · Male · 2022-06-29
Timeline
-
2021-04-14
Dose 1 — Pfizer-BioNTech
-
2021-04-17
Registered in v-safe
- 2021-04-17
- 2021-04-18
- 2021-04-20
- 2021-04-21
- 2021-04-30
-
2021-05-05
Dose 2 — Pfizer-BioNTech
- 2021-05-05
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-19
- 2021-05-28
- 2021-06-02
- 2021-06-09
- 2021-06-16
- 2021-08-04
- 2021-11-03
-
2022-01-07
Dose 3 — Pfizer-BioNTech
- 2022-05-07
-
2022-07-08
Dose 4 — Pfizer-BioNTech
- 2022-08-02
- 2022-08-05
- 2022-08-12
- 2022-08-21
-
2022-10-07
Survey response — 3 months, dose 4MedDRA: Cough, Fatigue, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Congestion, cough, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-10
- 2023-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Pfizer-BioNTech | |
| 2 | 2021-05-05 | Pfizer-BioNTech | |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
| 4 | 2022-07-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-07 | Unsuccessful |
Free text
Release 12 — 3 months, dose 4
Symptoms: Congestion, cough, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release